All In MedTech

Device Trial Radar · NCT07228416

Milky Way Sensor Motion Validation

Milky Way Sensor: Device Validation for Non-Infiltrated Tissues

Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

20

Actual

Start

Feb 5, 2026

Primary completion

Feb 25, 2026

Study completion Feb 25, 2026

Sponsor

Lead sponsor
ivWatch, LLCNot on our public-company list
Sponsor type
Industry
First posted
Nov 14, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A single arm study of 20 adult volunteers to assess the safety and efficacy of the ivWatch sensors when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.

Conditions

  • Infiltration of Peripheral IV Therapy

Interventions

  • ivWatch Model 400Device

    The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Red Check IV Notification Rate Per DayTime frame: 24 Hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ivWatch LLC

    Newport News, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.